P. Castiel

Failure of antibiotic therapy in Staphylococcus epidermidis infection of implantable venous access devices in patients with AIDS, as documented by molecular typing.

M. Kazatchkine, L. Gutmann, J. Gilquin, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Double‐blind placebo‐controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease

A. Leplège, M. Kazatchkine, B. Debuire, 2001, Clinical endocrinology.

Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1alpha and RANTES correlate with virus load in human immunodeficiency virus infection.

C. Blondin, M. Kazatchkine, L. Weiss, 1997, The Journal of infectious diseases.

Low increase in serum lipids in patients receiving a combination of ritonavir, saquinavir and efavirenz

M. Kazatchkine, G. Peytavin, L. Weiss, 2002, HIV medicine.

Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy.

M. Kazatchkine, F. Clavel, G. Peytavin, 1999, AIDS.

Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease

M. Kazatchkine, L. Bélec, J. Gilquin, 1998, AIDS.

Phenotypic resistance to protease inhibitors in patients who fail on highly active antiretroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz.

M. Kazatchkine, F. Clavel, G. Peytavin, 2000, AIDS.

Lack of legal income is strongly associated with an increased risk of AIDS and death in HIV-infected injecting drug users.

F. Lert, M. Kazatchkine, C. Piketty, 1999, AIDS care.

Prevalence of and factors associated with depression among people living with HIV in France

F. Marion, M. Duracinsky, F. Lert, 2017, HIV medicine.